Literature DB >> 11267533

A gene polymorphism associated with posttransplant lymphoproliferative disorder.

A M VanBuskirk1, V Malik, D Xia, R P Pelletier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11267533     DOI： 10.1016/s0041-1345(00)02700-7

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  8 in total

Review 1.  Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.

Authors:  Deepa Jagadeesh; Bruce A Woda; Jacqueline Draper; Andrew M Evens
Journal:  Curr Treat Options Oncol       Date:  2012-03

2.  Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB beta2 microglobulin-deficient mice.

Authors:  Vera L Tarakanova; Felipe Suarez; Scott A Tibbetts; Meagan A Jacoby; Karen E Weck; Jay L Hess; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Gamma interferon blocks gammaherpesvirus reactivation from latency.

Authors:  Ashley L Steed; Erik S Barton; Scott A Tibbetts; Daniel L Popkin; Mary L Lutzke; Rosemary Rochford; Herbert W Virgin
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

4.  Immune surveillance and lymphoid malignancy in immunocompromised host.

Authors:  Patrick L Stevens; Nishitha M Reddy
Journal:  Am J Blood Res       Date:  2013-05-05

5.  Murine gammaherpesvirus 68 genes both induce and suppress lymphoproliferative disease.

Authors:  Vera L Tarakanova; Friederike Kreisel; Douglas W White; Herbert W Virgin
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

Review 6.  Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies.

Authors:  Zeina Al-Mansour; Beverly P Nelson; Andrew M Evens
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

7.  Tumour necrosis factor gene polymorphism: a predictive factor for the development of post-transplant lymphoproliferative disease.

Authors:  K A McAulay; T Haque; D H Crawford
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

Review 8.  Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?

Authors:  J Morscio; D Dierickx; T Tousseyn
Journal:  Clin Dev Immunol       Date:  2013-04-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.